Feb 12 (Reuters) - Gentian Diagnostics ASA GENT.OL :
* Q4 SALES OF NOK 42.6 MILLION
* Q4 IMPROVEMENT OF GROSS MARGIN TO 56%
* Q4 EBITDA IMPROVEMENT TO NOK 8.1 MILLION IN 4Q24 VERSUS
NOK -1.0
MILLION IN 4Q23
* Q4 NET PROFIT OF NOK 45.3 MILLION
* BOARD PROPOSES A DIVIDEND OF NOK 0.40 PER SHAR
* TARGETS A MARKET SHARE OF 15- 20% FOR ITS PRODUCT
PORTFOLIO
* EXPECTS REVENUE TAKE WILL VARY ACROSS PRODUCTS BUT REMAIN
WITHIN
30-50% RANGE FOR PRODUCT PORTFOLIO AS A WHOLE
Source text: ID:nObiT98bba
Further company coverage: GENT.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))